COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,367 Articles (22,803 medRxiv, 8,564 bioRxiv)

Most recent first Previous |  Page 1351: Articles 13501-13510  | Next

SARS-CoV-2 in the Republic of Guinea: Fragment and Whole-Genome Sequencing, Phylogenetic Analysis
Kritsky, A. A., Krasnov, Y. M., Keita, M., Keita, S., Fedorov, A. V., Shevtsova, A. P., Guseva, N. P., Kazorina, E. V., Sosedova, E. A., Katyshev, A. D., Naryshkina, E. A., Kolomoets, E. V., Shcherbakova, S. A., Popova, A. Y., Kutyrev, V. V.
10.1101/2021.07.28.454098 — Posted: 2021-07-28
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine
Kramer, K. J., Wilfong, E. M., Voss, K., Barone, S., Shiakolas, A. R., Raju, N., Roe, C. E., Suryadevara, N., Walker, L. M., Wall, S. C., Paulo, A., Schaefer, S., Dahunsi, D., Westlake, C. S., Crowe, J. E., Carnahan, R. H., Rathmell, J. C., Bonami, R. H., Georgiev, I. S., Irish, J. M.
10.1101/2021.07.28.453981 — Posted: 2021-07-28
Monitoring and forecasting the SARS-Covid-19 pandemic in France
Reingruber, J., Papale, A., Ruckly, S., Timsit, J.-F., Holcman, D.
10.1101/2021.07.28.21260870 — Posted: 2021-07-28
Higher serological responses and increased vaccine effectiveness demonstrate the value of extended vaccine schedules in combatting COVID-19 in England
Amirthalingam, G., Lopez Bernal, J., Andrews, N. J., Whitaker, H., Gower, C., Stowe, J., Tessier, E., Subbarao, S., Ireland, G., Baawuah, F., Linley, E., Warrener, L., O'Brien, M., Whillock, C., Moss, P., Ladhani, S. N., Brown, K. E., Ramsay, M. E.
10.1101/2021.07.26.21261140 — Posted: 2021-07-28 Discussion: Onsite
COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study
Sun, J., Patel, R. C., Zheng, Q., Madhira, V., Olex, A. L., Islam, J. Y., French, E., Chiang, T. P.-Y., Akselrod, H., Moffitt, R., Alexander, G. C., Andersen, K. M., Vinson, A. J., Brown, T. T., Chute, C. G., Crandall, K. A., Franceschini, N., Mannon, R. B., Kirk, G. D.
10.1101/2021.07.26.21261028 — Posted: 2021-07-28
Streptococcus pneumoniae colonisation associates with impaired adaptive immune responses against SARS-CoV-2
Mitsi, E., Reine, J., Urban, B. C., Solorzano, C., Nikolaou, E., Hyder-Wright, A. D., Pojar, S., Howard, A., Hitchins, L., Glynn, S., Farrar, M., Liatsikos, K., Collins, A. M., Walker, N. F., Hill, H., German, E. L., Cheliotis, K. S., Byrne, R. L., Williams, C. T., Cubas Atienzar, A. I., Fletcher, T., Adams, E. R., Draper, S. J., Pulido, D., Beavon, R., Begier, E., Theilacker, C., Jodar, L., Gessner, B. D., Ferreira, D. M.
10.1101/2021.07.22.21260837 — Posted: 2021-07-28
Vaccine effectiveness when combining the ChAdOx1 vaccine as the first dose with an mRNA COVID-19 vaccine as the second dose
Gram, M. A., Emborg, H.-D., Moustsen-Helms, I. R., Nielsen, J., Sørensen, A. K. B., Valentiner-Branth, P., Schelde, A. B., Nielsen, K. F.
10.1101/2021.07.26.21261130 — Posted: 2021-07-28
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
Thomas, S. J., Moreira, E. D., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Marc, G. P., Polack, F. P., Zerbini, C., Bailey, R., Swanson, K. A., Xu, X., Roychoudhury, S., Koury, K., Bouguermouh, S., Kalina, W. V., Cooper, D., Frenck, R. W., Hammitt, L. L., Türeci, O., Nell, H., Schaefer, A., Ünal, S., Yang, Q., Liberator, P., Tresnan, D. B., Mather, S., Dormitzer, P. R., Sahin, U., Gruber, W. C., Jansen, K. U., C4591001 Clinical Trial Group
10.1101/2021.07.28.21261159 — Posted: 2021-07-28 Discussion: Onsite | Offsite
Immune responses to a single dose of the AZD1222/Covishield vaccine at 16 weeks in individuals in Sri Lanka
Jeewandara, C., Guruge, D., Pushpakumara, P., Kamaladasa, A., Aberathna, I., Tanussiya, S., Gunasekera, B., Wijesinghe, A., Dissanayaka, O., Kuruppu, H., Ranasinghe, T., Jayathilaka, D., Dayaratne, S., Ekanayaka, D., Jayamali, M., Gamalath, N., Mudunkotuwa, A., Somathilaka, G., Dissanayaka, M., Harvie, M., Nimasha, T., Madushanka, D., Jayadas, T., Wijayamuni, R., Schimanski, L., Rijal, P., Tan, T., Townsend, A., Ogg, G., Malavige, G. N.
10.1101/2021.07.26.21261122 — Posted: 2021-07-28
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner
Keeton, R., Richardson, S. I., Moyo-Gwete, T., Hermanus, T., Tincho, M. B., Benede, N., Manamela, N. P., Baguma, R., Makhado, Z., Ngomti, A., Motlou, T., Mennen, M., Chinoyi, L., Skelem, S., Maboreke, H., Doolabh, D., Iranzadeh, A., Otter, A., Brooks, T., Noursadeghi, M., Moon, J., Blackburn, J., Hsiao, N.-Y., Williamson, C., Riou, C., Goga, A., Garrett, N., Bekker, L.-G., Gray, G., Ntusi, N. A. B., Moore, P. L., Burgers, W. A.
10.1101/2021.07.24.21261037 — Posted: 2021-07-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).